BG Medicine Enters Into Research Collaboration With Merck
BG Medicine is expected to pursue development and validation of an immunoassay and investigate its clinical utility as a biomarker. If successful, BG Medicine plans to complete the
The US Food and Drug Administration (FDA) has expanded the approved indication for Bristol Myers Squibb’s (BMS) Camzyos (mavacamten) to treat symptomatic obstructive hypertrophic cardiomyopathy (oHCM) in adults and paediatric patients weighing at least 30kg (66lb).
In the new study of treatment-experienced HIV-1-infected adults with no Prezista resistance-associated mutations (RAMs), 72% of patients in the Prezista/ritonavir (800/100 mg) once-daily arm achieved undetectable viral loads
ProVation Medical provides procedure documentation and clinical decision support solutions for hospitals and ambulatory surgery centers. ProVation MD, ProVation MultiCaregiver and ProVation EHR software reduce transcription, paper storage